PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study.

• Tác giả: Muhammad Ali, Lewis Au, Arun A Azad, Mathias Bressel, James P Buteau, Sarat Chander, David Chang, Renu Eapen, Michael S Hofman, Nathan Lawrentschuk, Sidney M Levy, Jamil Manji, Daniel Moon, Declan G Murphy, Marlon Perera, Mark Shaw, Shankar Siva, Lavinia Spain, Ben Tran, Cristian Udovicich
• Ngôn ngữ: eng
• Ký hiệu phân loại: 339.523 Budget surpluses and deficits
• Thông tin xuất bản: United States : Journal of nuclear medicine : official publication, Society of Nuclear Medicine , 2025
• Bộ sưu tập: NCBI
• ID: 233602

Tóm tắt

Metastasis-directed therapy (MDT) in oligometastatic renal cell carcinoma (RCC) is typically based on conventional imaging. Prostate-specific membrane antigen (PSMA) PET/CT has shown superiority over conventional imaging. Our objective was to perform a proof-of-concept study to evaluate the efficacy of PSMA-guided MDT in oligometastatic RCC.